PerpEquities

Equity · Healthcare

Stryker Corporation (SYK) perpetual futures

SYK perpetual futures on 3 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade SYKUSDT.

Stryker Corporation is a medical technology company with two divisions: Orthopaedics and Spine implants, and MedSurg and Neurotechnology devices, sold to hospitals and clinicians in about 75 countries.

$344.29+9.4%NYSE open
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NYSE:SYK

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

3/3 live markets
Venues
3
Live markets
3/3
24h volume
$302.8K
Open interest
$235.8KCoverage: 2/3 markets
Best liquidity
$63.1K
MEXC
Tightest spread
+10.5 bps
BingX
Highest volume
$194.2K
BingX
Settlement mix
USDT · 3/3
Perp/spot vol.
0.00x
Spot volume $2.2B
OI / float
0.00%
Float $119B
Spot performance
1D+9.37%
5D+17.95%
1M+19.08%
6M+15.04%
YTD-3.36%
1Y-5.04%

Venue matrix

3 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeSYKUS-USDTTrading$344.24-1.1% APR
-0.00100% every 8h		+10.5 bps-$194.2K-USDT-
MEXCTradeSYK/USDTTrading$344.29+0.9% APR
+0.00080% every 8h		+29.9 bps$63.1K$105.6K$110.6KUSDT20x
Gate.ioTradeSYK/USDTTrading$343.400.0% APR
0.000% every 8h		+81.5 bps-$3K$125.3KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 3 venues absorb $10k · Typical cost: +29.0 bps

Cheapest execution: MEXC · +29.0 bps

No fresh book data: BingX, Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

SYK
MEXC · SYK/USDT$63.1K

Tightest spread

SYK
BingX · SYKUS-USDT+10.5 bps

Highest volume

SYK
BingX · SYKUS-USDT$194.2K

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-10-30 · next report 2027-02-04 · Updated 87h ago
All financials →

Valuation & key figures

Market cap
$111.9B
Updated 87h ago
Revenue
$26.3B
Trailing 12 months
Revenue growth
+7%
Next fiscal year
Profit margin
+13.8%
P/E
30.9
Peer P/E 19.6
P/S
4.3
Peer P/E
19.6
Similar listed perps
Free cash flow
$4.6B
Trailing 12 months
Net income
$3.6B
Trailing 12 months
Revenue estimate
$26.9B
Next fiscal year
Earnings
2027-02-04
Revenue est. $7.7B · Updated 87h ago
Dividend
$0.88
2026-09-30
Revenue (TTM)$26.3B+7.9% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)21.3%+0.4 pp vs a year agoOperating income $5.59B
Net income (TTM)$3.62B+23.1% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$4.57B+12.3% vs a year agoCapex $873M
Diluted EPS (TTM)$9.39+23.4% vs a year agoSum of the last 4 quarters
Net cash-$12.2B+14.2% vs a year agoCash + short-term investments - debt
  • Last report (2026-10-29): revenue missed by 1.5%, EPS missed by 0.8%Revenue $6.52B vs $6.62B expected (-1.5%); EPS $3.52 vs $3.55 (-0.8%).
  • Revenue growth steady: 7.6% year on yearQ3 '26 revenue $6.52B, against an average of 8.4% over the four quarters before.
  • Operating margin 21.3% (TTM), +0.4 pp on a year agoOperating income grew 9.8% while revenue grew 7.9%.
  • Capex 3.3% of revenue (a year ago 3.1%)$873M invested in the last 4 quarters (+15.0% on a year earlier). Free cash flow $4.57B = 126.2% of net income.

Revenue, operating income and growth

quarterly

Segments in Q3 '26

from the filing
SegmentRevenuey/yOp. incomeMargin
Med Surg And Neurotechnology$3.66B+9.2%$1.05B28.7%
Orthopaedics And Spine$2.86B+5.7%––
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 285 lines Stryker Corporation reported to the SEC

Next catalyst

Catalysts

Earnings
2027-02-04
Revenue est. $7.7B · Updated 87h ago
Dividend
$0.88
2026-09-30

No unusual perp activity right now.

Reference data

Market context

Reference market

Open
New York Stock Exchange
Regular hours
09:30 AM – 04:00 PM
Next holiday
Nov 26, 2026 · Thanksgiving Day

After-hours reference

Bid342.69
Ask348.77
Volume269,580

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202614.86$26.9B+7%15
FY 202716.36$28.9B+15%16
FY 202818.18$31.2B+24%10
FY 202919.94$33.4B+33%4
FY 203021.65$35.3B+41%4
Q1 20273.28$6.6B+10%8

Company events

6
2027-02-04EarningsActual - / Estimate 5.04-
2026-10-29Earnings · After market closeActual 3.52 / Estimate 3.55Miss
2026-09-30Dividend$0.88-
2026-07-30EarningsActual 3.69 / Estimate 3.49Beat
2026-06-30Dividend$0.88-
2026-04-30EarningsActual 2.6 / Estimate 2.98Miss

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
MRNA$103.2B46.3-32.4-141.4%23HCA$102.5B1.357.5+8.6%2CVS$102.3B0.29.2+2.6%3MCK$124.6B0.327.4+1.1%2REGN$99B5.920.5+28.5%7BMY$127.7B2.613.8+18.5%1ELV$95.4B0.518.7+2.5%2MDT$134.3B3.625.7+13.9%9

Company data

Company intelligence

Updated: Nov 3, 2026, 12:16 AM UTC

Company profile

Sector
Healthcare
Industry
Medical - Devices
Chief executive
Kevin A. Lobo
Employees
56,000
IPO date
Mar 17, 1980
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei4.58
Piotroski scorei9/9
Overall ratingiB+
Owner earningsi$1.31B$3.41 per share
ESG risk ratingiBIndustry rank: 57 out of 170

Rating factors

Return on equityi
4
Return on assetsi
5
Debt to equityi
1
Price to earningsi
2
Price to booki
2

Company press releases

Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSSPRNewsWireStryker reports third quarter 2026 operating resultsGlobeNewsWireStryker to participate in the 2026 Jefferies Global Healthcare ConferenceGlobeNewsWireStryker completes acquisition of ZuriMED to enhance its shoulder offeringGlobeNewsWireSecurities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmGlobeNewsWireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYKPRNewsWire

Congressional disclosures

Senate

House

Market cap history
$111.55B-14.8%Aug 26 – Oct 26
$105.15B$118.89B$132.62BHigh: $132.62B · 2026-08-10Low: $105.15B · 2026-09-21Latest: $111.55B · 2026-10-30Aug 26Sep 26Oct 26
Latest: $111.55B · 2026-10-30High: $132.62B · 2026-08-10Low: $105.15B · 2026-09-21
Largest fund holders
FundWeightShares held
VECA.S0.22%11.9M
VTI0.13%11M
VOO0.15%9.2M
IVV0.16%4.7M
1657.T0.12%4.7M
XSP.TO0.16%4.6M
XWD.TO0.12%4.6M
VCPA.S0.09%4.5M
FXAIX0.15%4.3M
SPY0.16%4.3M
VTV0.36%3.3M
XLV1.63%2.6M

Analyst track record

How the analysts covering SYK have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings170433
Analysts3741
Buy / hold / sell147 / 23 / 0359 / 74 / 0
Upgrades / downgrades / initiations4 / 1 / 57 / 1 / 9
Price targets hit / missed2 / 150 (1%)10 / 380 (3%)
Avg. return after a rating (TipRanks)-22.0%-20.6%
Best / worst call+4.6% / -33.5%+5.7% / -33.5%

After buy calls on this stock: median 21-day move +1.4% vs S&P 500 0.0% (n = 355)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Ryan ZimmermanBTIG73% hit rate on this stock · 26 targets measuredBuytarget $304Oct 29, 2026
  2. Vijay KumarEvercore ISI60% hit rate on this stock · 10 targets measuredBuytarget $320Oct 30, 2026
  3. Larry BiegelsenWells Fargo56% hit rate on this stock · 16 targets measuredBuytarget $348Sep 16, 2026

Latest ratings

DateAnalystCallTarget
Nov 2, 2026Mike KratkyLeerink PartnersBuyMaintained$340article ↗
Nov 2, 2026Patrick WoodUBSBuyMaintained$364article ↗
Nov 2, 2026Richard NewitterTruist FinancialHoldMaintained$305article ↗
Nov 2, 2026Rick WiseStifel NicolausBuyMaintained$325article ↗
Nov 2, 2026Caitlin RobertsCanaccord GenuityHoldDowngraded$300article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$280$300$320$340$360$380$400$420$440Dec 25 · Buy 19 · Hold 3 · Sell 0Dec 25Jan 26 · Buy 19 · Hold 5 · Sell 0Feb 26 · Buy 20 · Hold 5 · Sell 0Feb 26Mar 26 · Buy 22 · Hold 4 · Sell 0Apr 26 · Buy 22 · Hold 4 · Sell 0Apr 26May 26 · Buy 22 · Hold 5 · Sell 0Jun 26 · Buy 22 · Hold 5 · Sell 0Jun 26Jul 26 · Buy 27 · Hold 5 · Sell 0Aug 26 · Buy 28 · Hold 5 · Sell 0Aug 26Sep 26 · Buy 26 · Hold 4 · Sell 0Oct 26 · Buy 26 · Hold 3 · Sell 0Oct 26Nov 26 · Buy 26 · Hold 3 · Sell 0Dec 25 · avg. target $434Jan 26 · avg. target $430Feb 26 · avg. target $429Mar 26 · avg. target $432Apr 26 · avg. target $426May 26 · avg. target $397Jun 26 · avg. target $397Jul 26 · avg. target $390Aug 26 · avg. target $390Sep 26 · avg. target $375Oct 26 · avg. target $353Nov 26 · avg. target $353Dec 25 · month-end close $351Jan 26 · month-end close $370Feb 26 · month-end close $387Mar 26 · month-end close $329Apr 26 · month-end close $315May 26 · month-end close $305Jun 26 · month-end close $315Jul 26 · month-end close $326Aug 26 · month-end close $324Sep 26 · month-end close $275Oct 26 · month-end close $292Nov 26 · month-end close $292

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 2, 2026 · 170 ratings

Frequently asked questions

Where can I trade SYK perpetual futures?

Stryker Corporation (SYK) perpetual futures trade on 3 crypto venues, including BingX, MEXC, Gate.io. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade SYK around the clock?

Yes. Unlike the underlying stock, SYK perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on SYK perpetuals?

Right now the SYK perp funding rate is 0.0% annualized (venue median), ranging from -1.1% to +0.9% across 3 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the SYK perp price compare to the Stryker Corporation stock?

The venue-median SYK perp mark is $344.2 versus a reference stock price of $344.3, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a SYK perpetual future?

A SYK perpetual is a derivative that tracks the price of Stryker Corporation with no expiry date. It lets you take long or short exposure to Stryker Corporation on crypto venues, around the clock.

What is SYKUSDT perpetual?

SYKUSDT is the symbol most crypto exchanges use for the Stryker Corporation perpetual settled in USDT (Tether). It tracks the SYK share price through an index, trades 24/7 with leverage and never expires.

Other Healthcare perps

Also listed on BingX

Also listed on MEXC

Also listed on Gate.io

Embed this asset

SYK perpetuals · perpequities.comSYK perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/syk-perp"><img src="https://perpequities.com/badge/syk-perp.svg" width="240" height="64" alt="SYK perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Next step

Stay on top of SYK perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for SYK — one email every Sunday.

Watchlist and alerts

Price and funding alerts for SYK, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X